02:10 , Mar 10, 2010 |  BC Extra  |  Financial News

BT Pharma raises EUR 13.1 million

BT Pharma S.A. (Labege, France) raised EUR 13.1 million ($17.8 million) in a series B round led by new investor AGF. Additional new investors Institut Regional de Developpement Industriel; Amundi Private Equity Funds; and InnoBio...
07:00 , Oct 13, 2008 |  BC Week In Review  |  Company News

BT Pharma board of directors update

BT Pharma S.A. , Labege, France   Business: Cancer   Appointed: Thierry Hercend as president of the supervisory board, formerly VP of oncology research at sanofi-aventis Group  ...
08:00 , Jan 21, 2008 |  BC Week In Review  |  Company News

BT Pharma, Institut Pasteur deal

The parties amended a 2002 deal to give BT Pharma rights to combine cyclophosphamide or other undisclosed chemotherapies and an immunotherapy delivered using adenylate cyclase vector technology to treat cancer. Under the original deal, BT...
07:00 , Sep 24, 2007 |  BC Week In Review  |  Company News

BT Pharma management update

BT Pharma S.A. , Labege, France   Business: Cancer   Hired: Martin Koch as VP of finance and administration, formerly sales director of the oncology division at Cephalon Inc. 's Cephalon Europe unit  ...
07:00 , May 29, 2006 |  BC Week In Review  |  Company News

BT Pharma board of directors update

BT Pharma S.A. , Toulouse, France   Business: Cancer, Infectious   Appointed: Christian Policard, founding partner of Biotech Developpement Conseil  ...